Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
101.85B
Market cap101.85B
Price-Earnings ratio
20.99
Price-Earnings ratio20.99
Dividend yield
3.64%
Dividend yield3.64%
Average volume
11.02M
Average volume11.02M
High today
$79.77
High today$79.77
Low today
$78.20
Low today$78.20
Open price
$78.83
Open price$78.83
Volume
677.81K
Volume677.81K
52 Week high
$106.33
52 Week high$106.33
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

Medtronic(MDT) stock is priced at $79.57, giving the company a market capitalization of 101.85B. It carries a P/E multiple of 20.99 and pays a dividend yield of 3.64%.

On 2026-07-01, Medtronic(MDT) stock traded between a low of $78.20 and a high of $79.77. Shares are currently priced at $79.57, which is +1.8% above the low and -0.3% below the high.

Medtronic(MDT) shares are trading with a volume of 677.81K, against a daily average of 11.02M.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $73.31.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $73.31.

MDT News

Investing.com 2d
MiniMed adds Alcon CEO and Medtronic executive to board - Investing.com

...

MiniMed adds Alcon CEO and Medtronic executive to board - Investing.com
Simply Wall St 3d
Is Medtronic A Bargain After Renal Denervation Optimism And Strong Revenue Growth?

Recent commentary on Medtronic (MDT) has focused on its cardiac ablation, diabetes care and hypertension franchises, with the FDA approved Symplicity Spyral ren...

Is Medtronic A Bargain After Renal Denervation Optimism And Strong Revenue Growth?
Simply Wall St 5d
Renal Denervation Momentum Could Be A Game Changer For Medtronic’s Chronic Disease Strategy

In recent months, analysts have highlighted Medtronic’s progress in its Symplicity Spyral renal denervation system, which already has FDA approval and is on tra...

Renal Denervation Momentum Could Be A Game Changer For Medtronic’s Chronic Disease Strategy

Analyst ratings

64%

of 33 ratings
Buy
63.6%
Hold
36.4%
Sell
0%

More MDT News

Simply Wall St 7d
AngloGold Ashanti Stock Leads 3 Dividend Powerhouses Worth A Closer Look

With central banks sending mixed signals and growth indicators pointing in different directions across the US, Europe and Asia, reliable income has become a pri...

AngloGold Ashanti Stock Leads 3 Dividend Powerhouses Worth A Closer Look

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.